- Applying Mass Spec-Based Methods to Infectious Disease
- Implementation of Mass Spectrometry in Clinical Microbiology
Plenary Keynote Session:
Regulation of LDTs and RUOs
Alberto Gutierrez, Ph.D., Deputy Director, Office of in vitro Diagnostic Device Evaluation and Safety, Food & Drug Administration
Moderated by: Franklin R. Cockerill, III, M.D., Ann and Leo Markin Professor of Microbiology & Medicine; Chair, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine; President and CEO, Mayo Medical Laboratories and Mayo Collaborative Services, Inc.
Position of IVDs on Regulatory Issues
Alan Mertz, President, American Clinical Laboratory Association (ACLA)
Andrew C. Fish, Executive Director, AdvaMedDx
Distinguished Speaker Faculty:
Robert Bonomo, M.D., Associate Professor of Medicine, Division of Infectious Disease and HIV Medicine, Case Western Reserve University
Richard R. Drake, Ph.D., Professor and Director, MUSC Proteomics Center, Medical University of South Carolina
Garth D. Ehrlich, Ph.D., Executive Director, Center for Genomic Sciences, Allegheny-Singer Research Institute
Daniel P. Fedorko, Ph.D., Microbiologist, NIH/CC/DLM/Microbiology Service
Mark Fisher, Ph.D., Assistant Professor of Pathology, The University of Utah, ARUP Institute for Clinical and Experimental Pathology
Christine C. Ginocchio, Ph.D., M.T. (ASCP), Chief, Division of Infectious Disease Diagnostics, Department of Pathology and Laboratory Medicine Professor, Hofstra University North Shore-LIJ School of Medicine North Shore-LIJ Health System Laboratories
Michael E. Hodsdon, M.D., Ph.D., Associate Professor of Laboratory Medicine and Pharmacology, Yale University School of Medicine
Anna F. Lau, Ph.D., Clinical Microbiology Fellow, Microbiology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health
Nathan A. Ledeboer, Ph.D., Assistant Professor of Pathology, Medical College of Wisconsin
Scott McKeown, Ph.D, R&D Consultant, Randox Laboratories Ltd.
Javad Parvizi, M.D., FRCS, Vice Chairman, Research; Director, Clinical Research, Rothman Institute
Robin Patel, M.D., Chair, Division of Clinical Microbiology, Consultant, Divisions of Clinical Microbiology and Infectious Diseases, Professor of Microbiology and Medicine, College of Medicine, Mayo Clinic
Christopher Rath, Ph.D., Scientist, Dorrestein Laboratory, University of California, San Diego
Donna M. Wolk, M.H.A., Ph.D., D.(ABMM), Division Chief, Clinical and Molecular Microbiology;
As part of the Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Emerging Molecular Markers of Cancer, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, Mass Spec for the Clinic), this event will bring together all of the major players in the evolving areas of diagnostics.
Those that register by June 1 will save up to $350.
To register and view the full agenda, visit http://www.NextGenerationDx.com/
To inquire about sponsorship/
Writers and editors are invited to attend. To request a press pass, email firstname.lastname@example.org.
About Cambridge Healthtech Institute (www.chicorporate.com)
CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI’s Media Group, which includes news websites and e-newsletters including Bio-IT World and eCliniqua. Founded in 1992, CHI strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments.
Cambridge Healthtech Institute